Michele Buemi

11.1k total citations · 2 hit papers
275 papers, 8.6k citations indexed

About

Michele Buemi is a scholar working on Nephrology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michele Buemi has authored 275 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Nephrology, 56 papers in Hematology and 50 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michele Buemi's work include Erythropoietin and Anemia Treatment (47 papers), Dialysis and Renal Disease Management (41 papers) and Acute Kidney Injury Research (25 papers). Michele Buemi is often cited by papers focused on Erythropoietin and Anemia Treatment (47 papers), Dialysis and Renal Disease Management (41 papers) and Acute Kidney Injury Research (25 papers). Michele Buemi collaborates with scholars based in Italy, United States and Belgium. Michele Buemi's co-authors include Antonio Lacquaniti, Davide Bolignano, Giuseppe Coppolino, Valentina Donato, N Frisina, Francesco Corica, Susanna Campo, Giacomo Nicocia, Carmela Aloisi and Domenico Santoro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Michele Buemi

273 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease

2002 672 citations Carmine Zoccali, Francesca Mallamaci et al. profile →
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease

2009 448 citations Davide Bolignano, Antonio Lacquaniti et al. profile →

Peers

Countries citing papers authored by Michele Buemi

Since Specialization

Citations

This map shows the geographic impact of Michele Buemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Buemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Buemi more than expected).

Fields of papers citing papers by Michele Buemi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Buemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Buemi. The network helps show where Michele Buemi may publish in the future.

Co-authorship network of co-authors of Michele Buemi

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Buemi. A scholar is included among the top collaborators of Michele Buemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Buemi. Michele Buemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 2022 ·International Urology and Nephrology ·Valeria Cernaro, Vincenzo Calabrese, Saverio Loddo, Roberta Corsaro, Vincenzo Macaione, (unknown), Rosalia Maria Cigala, Francesco Crea, Concetta De Stefano, Guido Gembillo, Adolfo Romeo, (unknown), Domenico Santoro, Michele Buemi, Salvatore Benvenga	7
2	Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology 2020 ·Journal of Nephrology ·Roberto Pontremoli, Vincenzo Bellizzi, Stefano Bianchi, Roberto Bigazzi, Valeria Cernaro, Lucia Del Vecchio, Luca De Nicola, Giovanna Leoncini, Francesca Mallamaci, Carmine Zoccali, Michele Buemi	13
3	Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis 2017 ·International Journal of Molecular Sciences ·Anna Pisano, Valeria Cernaro, Guido Gembillo, Graziella D’Arrigo, Michele Buemi, Davide Bolignano	46
4	Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 2017 ·PLoS ONE ·Davide Bolignano, Valeria Cernaro, Guido Gembillo, Rossella Baggetta, Michele Buemi, Graziella D’Arrigo	89
5	Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma 2016 ·International Journal of Molecular Sciences ·Marco Atteritano, Domenico Santoro, (unknown), Elisa Visalli, Michele Buemi, Antonino Catalano, Antonino Lasco, Alessandra Bitto, Francesco Squadrito	23
6	Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury 2015 ·BioMed Research International ·Natasha Irrera, Alessandra Bitto, Gabriele Pizzino, Mario Vaccaro, Francesco Squadrito, Mariarosaria Galeano, Francesco Stagno d’Alcontres, (unknown), Michele Buemi, Letteria Minutoli, Michele Rosario Colonna, Domenica Altavilla	9
7	An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 2015 ·Expert Opinion on Investigational Drugs ·Domenico Santoro, (unknown), Luca Visconti, Gianluca Trifirò, Michele Buemi, Valeria Cernaro	8
8	Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 2014 ·BioMed Research International ·Gianluca Trifirò, Janet Sultana, Francesco Giorgianni, Ylenia Ingrasciotta, Michele Buemi, (unknown), Daniele Ugo Tari, (unknown), (unknown), Vincenzo Arcoraci, Domenico Santoro	17
9	New therapeutic strategies under development to halt the progression of renal failure 2014 ·Expert Opinion on Investigational Drugs ·Valeria Cernaro, Gianluca Trifirò, (unknown), (unknown), Michele Buemi, Domenico Santoro	17
10	Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients 2009 ·Kidney & Blood Pressure Research ·Davide Bolignano, Antonio Lacquaniti, Giuseppe Coppolino, Valentina Donato, Maria Rosaria Fazio, Giacomo Nicocia, Michele Buemi	148
11	Down with the Erythropoietin. Long Live the Erythropoietin ! 2009 ·Current Drug Targets ·Michele Buemi, Antonio Lacquaniti, Davide Bolignano, Valeria Cernaro, Susanna Campo, Giovanni Grasso, Antoine Buemi, Valentina Donato, Alessio Sturiale	12
12	Osteoprotegerin and Bone Mineral Density in Hemodiafiltration Patients 2005 ·Renal Failure ·Alessandra Crisafulli, Adolfo Romeo, Fulvio Floccari, (unknown), Marco Atteritano, Maria Cincotta, Carmela Aloisi, M.A. Pizzoleo, Antonella Ruello, A. Artemisia, (unknown), N Frisina, (unknown), Michele Buemi	14
13	Leptin-dependent platelet aggregation in healthy, overweight and obese subjects 2003 ·International Journal of Obesity ·Andrea Corsonello, Francesco Perticone, Alba Malara, Domenico Majolino, Saverio Loddo, Michele Buemi, Riccardo Ientile, Francesco Corica	63
14	AQP1 in Red Blood Cells of Uremic Patients during Hemodialytic Treatment 2002 ·The Nephron journals/Nephron journals ·Michele Buemi, Fulvio Floccari, Giuseppe Di Pasquale, Giuseppina Cutroneo, Alessio Sturiale, Carmela Aloisi, Antonella Ruello, Adolfo Romeo, Angelo Favaloro, Francesco Corica, N Frisina, (unknown)	7
15	Recombinant Human Erythropoietin Influences Revascularization and Healing in a Rat Model of Random Ischaemic Flaps 2002 ·Acta Dermato Venereologica ·Michele Buemi, Mario Vaccaro, Alessio Sturiale, (unknown), Carlo Sansotta, Vittorio Cavallari, Fulvio Floccari, (unknown), Valerio Torre, Gioacchino Calapai, N Frisina, Fabrizio Guarneri, (unknown)	66
16	Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? 2002 ·Journal of neurosurgery ·Giovanni Grasso, Marcello Passalacqua, Alessandra Sfacteria, Alfredo Conti, Antonino Morabito, G. Mazzullo, Gionata De Vico, Michele Buemi, (unknown), Francesco Tomasello	31
17	Effects of Hormonal Replacement Therapy on Bone Metabolism in Young Adults with Beta-thalassemia Major 2001 ·Osteoporosis International ·Antonino Lasco, N. Morabito, Agostino Gaudio, Michele Buemi, Małgorzata Waśniewska, N Frisina	76
18	Plasma Leptin Concentrations in Relation to Sick Euthyroid Syndrome in Elderly Patients with Nonthyroidal Illnesses 2000 ·Gerontology ·Andrea Corsonello, Michele Buemi, A. Artemisia, Grazia Giorgianni, V Nicita Mauro, Francesco Corica	8
19	Pro-apoptotic effect of fluvastatin on human smooth muscle cells 1999 ·European Journal of Pharmacology ·Michele Buemi, Alessandro Allegra, Massimino Senatore, (unknown), Maria Antonietta Medici, Carmela Aloisi, (unknown), Francesco Corica	53
20	Plasma interleukin-2 levels and thyroid function in elderly patients with nonthyroidal illness 1998 ·Archives of Gerontology and Geriatrics ·Alessandro Allegra, Francesco Corica, Michele Buemi, Andrea Corsonello, Federico Maria Rubino, (unknown), (unknown), V Nicita Mauro, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact